Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Teasing Out Next-Generation Diabetes Drugs

Feb 01 2005

• By Wendy Diller

Related Content

Abbott/TheraSense: A Subtext Beyond the Diabetes Market?

Feb 01 2004

Amylin's Leap of Faith

Feb 01 2001

Drug Delivery Start-Ups

Jun 01 2000

Pitching Plenty to Many

May 01 2002

Plexxikon Inc.

Jul 01 2002

Watson's Strategy for Beating the Big Boys

Nov 01 2003

Bristol: Rebuilding a Diabetes Franchise--with Insulin

Oct 01 2003

A Coup for Nobex

Jun 01 2002

TheraSense's Sweet Spot

Jun 01 2002

Related Companies

Bristol Myers Squibb Company

Johnson & Johnson

Bristol Myers Squibb Company

Sanofi

Bayer AG

Takeda Pharmaceutical Co. Ltd.

GSK plc

Phenomix Corporation

Plexxikon, Inc.

Phenomix Corporation

7TM Pharma A/S

OSI Systems, Inc.

Prosidion Ltd.

Merck & Co., Inc.

Eli Lilly and Company

Wyeth

Pfizer Inc.

American Diabetes Association

DiaMedica Therapeutics Inc.

CymaBay Therapeutics, Inc.

Novartis AG

DiObex, Inc.

Pfizer Inc.

Sirtris Pharmaceuticals

Harvard University

Massachusetts Institute of Technology

CTI BioPharma Corp.

Allergan plc

Additional Topics

Business Strategies BioPharmaceutical

More from Strategy

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window